Menu
Menu
Menu

MULTIDISCIPLINAIR ZORGPAD HARTFALEN

Multidisciplinary heart failure care path

Care Pathway

This care path is a tool for every doctor and healthcare provider in the follow-up and treatment of patients with heart failure. On this website you will find all the necessary information about the diagnosis, optimal treatment, follow-up and what to do in case of problems during the follow-up of a patient with heart failure. The information and advice are based on the most recent ESC guidelines, the Belgian WOREL guidelines for general practitioners, scientific knowledge and practical clinical experience. We hope that patients with heart failure will be continuously monitored, advised and treated by every healthcare provider as optimally as possible and in a similar manner.

As a patient, you can also find practical information and advice on how to monitor yourself, what the alarm symptoms are and how to live with heart failure.

To quickly find the desired information, you can click on the desired part of this diagram.

27 March 2026

The general practitioner can now also extend the reimbursement of SGLT-2 inhibitors for heart failure (in Belgium)!

For several years, treatment with an SGLT-2 inhibitor has been strongly recommended for all heart failure patients, regardless of the...
15 January 2026

New treatment for cardiac ATTR amyloidosis reimbursed: Beyonttra

Beyonttra (acoramidis) 356 mg is reimbursed in Belgium from January 1, 2026, for the treatment of wild-type or hereditary transthyretin...
14 January 2026

Article in World Health Leaders in December 2025: Innovating Heart Failure Management Beyond Traditional Guidelines

In December 2025, a compelling article was published in the US-based international magazine World Health Leaders. The care pathway and...
crossmenuarrow-right-circle